N-(2-(6,6-DIMETHYL-4,5,6,7-TETRAHYDRO-1H-INDAZOL-3-YL)-1H-INDOL-6-YL)-N-METHYL-2-MORPHOLINOPROPANAMIDE, (S)-
UNII P0BJU71YZI
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(2-(6,6-dimethyl-4,5,6,7-tetrahydro-1h-indazol-3-yl)-1h-indol-6-yl)-n-methyl-2-morpholinopropanamide, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P0BJU71YZI.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1309784-09-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H33N5O2 ZZZXGCPVQQOASC-INIZCTEOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(2-(6,6-dimethyl-4,5,6,7-tetrahydro-1h-indazol-3-yl)-1h-indol-6-yl)-n-methyl-2-morpholinopropanamide, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.